Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | SQLE | Q14534 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL847999 | 1.00 | TSHR (0.48) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL7624837 | 0.91 | TSHR (0.40) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL846897 | 0.86 | KMT2A (0.46) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL846896 | 0.86 | KMT2A (0.46) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL8385489 | 0.86 | TSHR (0.56) | TSHRALDH1A1LSSSQLEMAPT | |
| SCHEMBL8385488 | 0.86 | TSHR (0.56) | TSHRALDH1A1LSSSQLEMAPT | |
| SCHEMBL1136744 | 0.85 | TSHR (0.58) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL1136745 | 0.85 | TSHR (0.58) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL29284342 | 0.83 | TSHR (0.56) | TSHRALDH1A1LSSKMT2ASQLE | |
| SCHEMBL999077 | 0.83 | TSHR (0.64) | TSHRALDH1A1LSSKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882283-A1 | ETHYLENE-COPOLYMERS AND CATALYST MIXTURE FOR MAKING ETHYLENE COPOLYMERS | Arlanxeo Netherlands B.V. (NL) | 2021-09-22 | — | — | EP | claimed |
| US-9382344-B2 | Mitigation of catalyst inhibition in olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-07-05 | — | — | US | claimed |
| EP-3013867-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2016-05-04 | — | — | EP | claimed |
| WO-2014209813-A1 | MITIGATION OF CATALYST INHIBITION IN OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-12-31 | — | — | WO | claimed |
| US-20140378732-A1 | Mitigation of Catalyst Inhibition in Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-12-25 | — | — | US | claimed |
| EP-1016689-B1 | Olefin thermoplastic elastomer compositions | MITSUI CHEMICALS INC (JP) | 2007-03-07 | — | — | EP | claimed |
| EP-0506076-B1 | Polyphenylene ether/polyolefin resin composition | MITSUBISHI CHEM CORP (JP) | 1996-07-24 | — | — | EP | claimed |
| US-5418287-A | Impact strength, blend | MITSUBISHI PETROCHEMICAL COMPANY, LTD. (JP) | 1995-05-23 | — | — | US | claimed |
| EP-0506076-A2 | Polyphenylene ether/polyolefin resin composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-09-30 | — | — | EP | claimed |
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | ARLANXEO NETHERLANDS B.V. (NL) | 2026-02-24 | — | — | US | disclosed |
| EP-4632001-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND MOLDED ARTICLE COMPRISING SAME | Mitsui Chemicals, Inc. (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-20250313041-A1 | TIRE COMPOSITIONS COMPRISING FUNCTIONALIZED RUBBERS BASED ON ETHYLENE-COPOLYMERS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-10-09 | — | — | US | disclosed |
| EP-4043500-B1 | ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| EP-4330297-B1 | METAL COMPLEX CATALYST FOR THE POLYMERIZATION OF OLEFINS | Arlanxeo Netherlands Bv (NL) | 2025-07-30 | — | — | EP | disclosed |
| EP-0512741-A1 | Process for producing a propylene random copolymer | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-11-11 | — | — | EP | disclosed |
| EP-0506076-A2 | Polyphenylene ether/polyolefin resin composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-09-30 | — | — | EP | disclosed |
| EP-0484941-A2 | Thermoplastic resin composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-05-13 | — | — | EP | disclosed |
| EP-0467261-A2 | Thermoplastic polyphenylene ether resin composition | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1992-01-22 | — | — | EP | disclosed |
| EP-0452156-A2 | Solid titanium catalyst component for olefin polymerization, olefin polymerization catalyst, prepolymerized polyolefin-containing catalyst and method of olefin polymerization | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
| EP-0423363-A1 | HIGHER $g(a)-OLEFIN COPOLYMER, METHOD OF PRODUCTION THEREOF, PRODUCT OF VULCANIZATION THEREOF, AND VULCANIZABLE RUBBER COMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1991-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559581-B2 | Ethylene-copolymers and catalyst mixture for making ethylene copolymers | EEF1D, COG7, CCND1 | TSHR 3104/4885ALDH1A1 3591/4885LSS 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.